These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8170465)

  • 1. On the expression of the p53 protein in human cancer.
    Lane DP
    Mol Biol Rep; 1994 Jan; 19(1):23-9. PubMed ID: 8170465
    [No Abstract]   [Full Text] [Related]  

  • 2. The p53 tumour suppressor gene and product.
    Levine AJ
    Cancer Surv; 1992; 12():59-79. PubMed ID: 1638548
    [No Abstract]   [Full Text] [Related]  

  • 3. p53 and human cancers.
    Lane DP
    Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of phosphoprotein P53 in pathology].
    Casazza S
    Pathologica; 1993; 85(1097):321-34. PubMed ID: 8233649
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploiting the p53 pathway for cancer diagnosis and therapy.
    Lane DP
    Br J Cancer; 1999 Jul; 80 Suppl 1():1-5. PubMed ID: 10466753
    [No Abstract]   [Full Text] [Related]  

  • 6. Looking at p53: theoretical implications and methodological aspects.
    Opalka B; Kasimir-Bauer S
    Arch Toxicol Suppl; 1997; 19():17-28. PubMed ID: 9079191
    [No Abstract]   [Full Text] [Related]  

  • 7. The p53 tumour suppressor protein.
    Hickman ES; Helin K
    Biotechnol Genet Eng Rev; 2000; 17():179-211. PubMed ID: 11255666
    [No Abstract]   [Full Text] [Related]  

  • 8. The expanding universe of p53 targets.
    Menendez D; Inga A; Resnick MA
    Nat Rev Cancer; 2009 Oct; 9(10):724-37. PubMed ID: 19776742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53: balancing tumour suppression and implications for the clinic.
    Buganim Y; Rotter V
    Eur J Cancer; 2009 Sep; 45 Suppl 1():217-34. PubMed ID: 19775621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?
    Workman P
    Hum Exp Toxicol; 1995 Feb; 14(2):222-5. PubMed ID: 7779451
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Greenblatt MS; Bennett WP; Hollstein M; Harris CC
    Cancer Res; 1994 Sep; 54(18):4855-78. PubMed ID: 8069852
    [No Abstract]   [Full Text] [Related]  

  • 12. p53: from clinical significance to significance in the clinic?
    Hall AR; Braithwaite A
    N Z Med J; 1997 Sep; 110(1052):347-8. PubMed ID: 9364174
    [No Abstract]   [Full Text] [Related]  

  • 13. p53 in growth control and neoplasia.
    Gottlieb TM; Oren M
    Biochim Biophys Acta; 1996 Jun; 1287(2-3):77-102. PubMed ID: 8672531
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances on mutant p53 research].
    Li DH; Zhang LQ; He FC
    Yi Chuan; 2008 Jun; 30(6):697-703. PubMed ID: 18550490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the origins of tumor mutations in cancer genes: insights from the p53 gene.
    Hollstein M; Moeckel G; Hergenhahn M; Spiegelhalder B; Keil M; Werle-Schneider G; Bartsch H; Brickmann J
    Mutat Res; 1998 Sep; 405(2):145-54. PubMed ID: 9748548
    [No Abstract]   [Full Text] [Related]  

  • 16. p53--a natural cancer killer: structural insights and therapeutic concepts.
    Römer L; Klein C; Dehner A; Kessler H; Buchner J
    Angew Chem Int Ed Engl; 2006 Oct; 45(39):6440-60. PubMed ID: 16983711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for manipulating the p53 pathway in the treatment of human cancer.
    Hupp TR; Lane DP; Ball KL
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):1-17. PubMed ID: 11062053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Another p53 Doppelgänger?
    Kaelin WG
    Science; 1998 Jul; 281(5373):57-8. PubMed ID: 9679018
    [No Abstract]   [Full Text] [Related]  

  • 19. The significance of p53 mutations in human cancers.
    Pellegata NS; Ranzani GN
    Eur J Histochem; 1996; 40(4):273-82. PubMed ID: 9116334
    [No Abstract]   [Full Text] [Related]  

  • 20. Methods for screening tumors for p53 status and therapeutic exploitation.
    Tullo A; D'Erchia AM; Sbisà E
    Expert Rev Mol Diagn; 2003 May; 3(3):289-301. PubMed ID: 12779005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.